OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural killer cell-related gene signature predicts malignancy of glioma and the survival of patients
Chenglong Li, Fangkun Liu, Lun‐Quan Sun, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 18

Showing 18 citing articles:

Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC
Hao Chi, Xixi Xie, Yingjie Yan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 91

A Trojan‐Horse‐Like Biomimetic Nano‐NK to Elicit an Immunostimulatory Tumor Microenvironment for Enhanced GBM Chemo‐Immunotherapy
Long Zhang, Yining Zhang, Xu Wang, et al.
Small (2023) Vol. 19, Iss. 44
Closed Access | Times Cited: 19

Identification of CKAP2 as a Potential Target for Prevention of Gastric Cancer Progression: A Multi-Omics Study
Xueyi Liu, Wenyu Zhang, Hui Wang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1557-1557
Open Access

Analysis of ABCC3 in glioma progression: implications for prognosis, immunotherapy, and drug resistance
Liang Shen, Haitao Shen, Tong Wang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access

Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification
Marco Cortese, Erica Torchiaro, Alice D'Andrea, et al.
Molecular Therapy (2024) Vol. 32, Iss. 8, pp. 2741-2761
Open Access | Times Cited: 3

Natural killer cell-related prognosis signature predicts immune response in colon cancer patients
Meiqin Li, Jingqing Song, Lin Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5

Prospective Molecular Targets for Natural Killer Cell Immunotherapy against Glioblastoma Multiforme
Luke C. Cooksey, Derek C. Friesen, Enrique D. Mangan, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1567-1567
Open Access | Times Cited: 1

Immune characteristics and genetic markers of esophageal cancer by single-cell analysis: implications for immunotherapy
Bing Xu, Ihsuan Tseng, Xiaofei Zhang, et al.
Journal of Thoracic Disease (2023) Vol. 15, Iss. 4, pp. 1805-1822
Open Access | Times Cited: 4

Prognostic Model for Clear-cell Renal Cell Carcinoma Based on Natural Killer Cell-related Genes.
Xuezhong Shi, Mengyang Yuan, Yongli Yang, et al.
Clinical Genitourinary Cancer (2022) Vol. 21, Iss. 3, pp. e126-e137
Closed Access | Times Cited: 4

Colorectal cancer subtyping and immune landscape analysis based on natural killer cell-related genes
Mei Ding, Jianchao Gao, Jinyan Wang, et al.
Arab Journal of Gastroenterology (2024) Vol. 25, Iss. 2, pp. 150-159
Closed Access

Tumor-treating fields increase cytotoxic degranulation of natural killer cells against cancer cells
Eimear Mylod, Gearóid Conlon, Elise P. W. Jenkins, et al.
Cell Reports Physical Science (2024) Vol. 5, Iss. 8, pp. 102119-102119
Open Access

A Novel Natural Killer Cell-related Gene Signature for Improving the Prediction of Prognosis and Immunotherapy Response in Bladder Cancer
MA Xu-dong, Xifeng Wei, Guanghua Yang, et al.
Combinatorial Chemistry & High Throughput Screening (2023) Vol. 27, Iss. 8, pp. 1205-1221
Open Access | Times Cited: 1

Page 1

Scroll to top